Bind Therapeutics

Pfizer Inc. (NYSE: PFE)'s acquisition of Medivation Inc (NASDAQ: MDVN) may have come as a surprise to some, but Pfizer has a long standing history of pursuing large scale M&A deals. With 2016 more than half over, Pfizer has already dished out $5.2 billion to acquire Anacor and $14 billion this...

BIND Therapeutics Inc (NASDAQ: BIND) is up on Thursday morning after reporting positive news at the close Wednesday. The company reported results of its ongoing Phase 2 study of BIND-014 in non-small cell lung cancer in the "once every three weeks" treatment arm. On November 19, the...